Autoimmune disease diagnostics: Key market research findings
- Discovery of novel biomarkers to boost market growth
- Localized autoimmune segment to account for a majority share of the market revenue
- Key vendors – Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Inova Diagnostics, Siemens, and Thermo Fisher Scientific
Technavio’s market research analysts predict the global autoimmune disease diagnostics market to grow at a CAGR of more than 6% between 2016 and 2020. The discovery of novel biomarkers is the primary driving force behind the growth of this market. Biomarkers linked to autoimmune diseases are being discovered and studied and is resulting in the development of new biomarker-specific diagnostic products. At present, the Americas dominate the market by accounting for more than 48% of the overall market share. The improved healthcare structure in the US and the evolving medical reforms in Canada are some of the factors that will propel the growth of the autoimmune diseases diagnostics market in the Americas during the forecast period.
The new market research report from Technavio presents a breakdown and analysis of the autoimmune disease diagnostics segments based on disease type.
“Increased focus on companion diagnostic tests is an ongoing trend in the market currently. Companion diagnostics enable the screening of individuals or groups who are likely to respond better to a therapeutic agent. The development of a companion diagnostic test for an autoimmune disease requires the use of a diagnostic test as well as monitoring of disease prognosis in the individual’s undergoing therapy,” says Barath Palada, Lead Analyst, Healthcare & Lifesciences, Technavio Research.
By 2020, the localized autoimmune segment will dominate the global autoimmune disease diagnostics market by accounting for a market share of around 57%. Some example of localized autoimmune diseases includes Type 1 diabetes, autoimmune thyroiditis, celiac disease, inflammatory bowel response, and primary biliary cirrhosis. This segment of the market is expected to flourish during the forecast period owing to the improved understanding of diseases that are specific to organs rather than autoimmune responses affecting many parts of the human system.
The key vendors in the market include Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Inova Diagnostics, Siemens Healthcare, and Thermo Fisher Scientific. The global autoimmune disease diagnostics market is fragmented due to the presence of several large and small vendors in the market. These vendors invest heavily in R&D to overcome the limitations of the available autoimmune disease diagnostic products and manufacture reliable testing assays and platforms. New vendors are focusing on understanding autoimmune diseases and associated pathologies and advances in genomics and proteomics for biomarker discovery to enter the market. Moreover, the market is attracting several new companies to launch new products as it has a moderate level of entry barrier. These players are constantly looking for ways to enhance their market presence by focusing on the implementation of various new technologies and M&A activities.
A more detailed analysis is available in the Technavio report, Global Autoimmune Disease Diagnostics Market 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
